← Back to Screener
Profusa, Inc. Common Stock (PFSA)
Price$0.65
Favorite Metrics
Price vs S&P 500 (26W)-101.64%
Price vs S&P 500 (4W)-18.59%
Market Capitalization$901,265
All Metrics
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-20.58
Price vs S&P 500 (YTD)-94.21%
EPS (TTM)$-183.27
10-Day Avg Trading Volume26.68M
EPS Excl Extra (TTM)$-183.27
EPS (Annual)$-110.00
ROI (Annual)17.25%
Cash / Share (Quarterly)$7.16
ROA (Last FY)-103.81%
EBITD / Share (TTM)$-23.21
Cash Flow / Share (Annual)$-16.54
P/B Ratio0.30x
ROA (TTM)-942.72%
EPS Incl Extra (Annual)$-110.00
Current Ratio (Annual)0.00x
Quick Ratio (Quarterly)0.17x
3-Month Avg Trading Volume3.41M
52-Week High$957.00
EPS Excl Extra (Annual)$-110.00
26-Week Price Return-97.66%
Quick Ratio (Annual)0.00x
13-Week Price Return-90.02%
Total Debt / Equity (Annual)0.16x
Current Ratio (Quarterly)0.18x
Enterprise Value$18.963
Cash / Share (Annual)$0.21
3-Month Return Std Dev345.97%
ROE (Last FY)20.06%
EPS Basic Excl Extra (Annual)$-110.00
Total Debt / Equity (Quarterly)0.54x
EPS Incl Extra (TTM)$-183.27
ROI (TTM)-16.62%
Revenue / Share (Annual)$0.00
Year-to-Date Return-91.56%
5-Day Price Return-36.86%
EPS Normalized (Annual)$-110.00
Month-to-Date Return30.77%
EBITD / Share (Annual)$-114.35
EPS Basic Excl Extra (TTM)$-183.27
Price vs S&P 500 (13W)-90.70%
Beta0.62x
Revenue / Share (TTM)$0.00
ROE (TTM)-22.12%
52-Week Low$0.41
Industry Peers — Surgical & Medical Instruments(109)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
PFSAProfusa, Inc. Common Stock | — | — | — | — | $0.65 |
SYKStryker Corporation | 5.15x | 11.84% | 64.57% | 19.43% | $338.38 |
BSXBoston Scientific Corp. | 4.76x | 15.16% | 69.01% | 18.00% | $63.42 |
MMM3M Company | 3.18x | -4.97% | 39.92% | 18.55% | $150.55 |
MDLNMedline Inc. Class A common stock | 2.21x | — | 26.44% | 7.78% | $46.94 |
BDXBecton, Dickinson and Co. | 2.01x | 6.32% | 46.42% | 12.15% | $154.82 |
RMDResMed Inc. | 6.06x | 11.72% | 60.85% | 33.70% | $224.72 |
DXCMDexCom, Inc. | 5.23x | 19.33% | 62.09% | 19.56% | $61.23 |
WSTWest Pharmaceutical Services, Inc. | 6.22x | 7.44% | 35.91% | 19.03% | $269.81 |
PODDInsulet Corporation | 5.31x | 24.53% | 71.63% | 12.92% | $201.47 |
PENPenumbra, Inc. | 9.31x | 20.16% | 67.14% | 13.48% | $331.47 |
About
Profusa is a clinical-stage medical technology company developing implantable biosensors designed to integrate with the body and continuously transmit clinical-grade health data. The company's technology enables real-time monitoring of biomarkers for various diseases and conditions. Its lead product, the Lumee Oxygen Platform, is available in the European Union and measures tissue oxygen levels for both acute and long-term patient monitoring.